Issue	Title
Fall 98-Winter 99	Celbrex: A Selective COX-2 Inhibitor Gets FDA Approval by June Dahl PhD
Summer 98	Darvon, a Drug with Dubious Distinction  by June Dahl, PhD
Spring 98	Marijuana and Pain  by June Dahl, PhD
Winter 98	Bisphosphonates  by June Dahl, PhD
Fall 97	Is it Pain or is it Addiction? (Part Two)  by David Weissman, MD
Summer 97	Is it Pain or is it Addiction? (Part One)   by David Weissman, MD
Spring 97	External Bone Radiation Therapy:    An Effective Tool to Manage Painful Bone Metastases   by Minesh Mehta, MD
Winter 97	Radioactive Strontium Therapy for the Palliation of Painful Bone Metastases   by Richard A. Steeves, MD, PhD
Fall 96	Assessment of the Patient with Non-Opioid Responsive Pain   by David E. Weissman, MD
Summer 96	Spinal Opioids and Implanted Pumps   by David E. Weissman, MD
Spring 96	The Three Faces of Fentanyl   Fentanyl Postcript (a follow-up article published in Fall 96)   by June Dahl, PhD
Winter 96	Nurses Talking to Doctors About Pain   by David E. Weissman, MD
Fall 95	Pharmacologic Management of Neuropathic Pain   by June Dahl, PhD
Summer 95	Tramadol: New Class of Analgesic for Mild to Moderate Pain   by June Dahl, PhD
Spring 95	The Difficult Pain Interview   by David E. Weissman, MD
Winter 95	Common Errors in Pain Management   by David E. Weissman, MD
Fall 94	Opioid Cost Factors   by Karen Kunz, RN, MS